PART 1: VASCULAR SURGERY PROSPECTIVE VALIDATION OF A PREDICTIVE SCORING SYSTEM FOR DEEP STERNAL WOUND INFECTION AFTER ROUTINE BILATERAL INTERNAL THORACIC ARTERY GRAFTING.- DEEP STERNAL INFECTION FOLLOWING BILATERAL INTERNAL THORACIC ARTERY GRAFTING.- PEDICLED AND SKELETONIZED SINGLE AND BILATERAL INTERNAL THORACIC ARTERY GRAFTS AND THE INCIDENCE OF STERNAL WOUND COMPLICATIONS.- DEEP STERNAL WOUND INFECTION AFTER CORONARY ARTERY BYPASS SURGERY: MANAGEMENT AND RISK FACTOR ANALYSIS FOR MORTALITY.- NEGATIVE PRESSURE WOUND THERAPY FOR HIGH-RISK WOUNDS IN LOWER EXTREMITY REVASCULARIZATION.- VACUUM-ASSISTED WOUND CLOSURE IN VASCULAR SURGERY.- BIOFILM IN INFECTIVE ENDOCARDITIS, EVIDENCE AND CLINICAL IMPLICATIONS.- A META-ANALYSIS OF PLATELET GEL FOR PREVENTION OF STERNAL WOUND INFECTIONS FOLLOWING CARDIAC SURGERY.- PREDICTORS OF DELAYED WOUND HEALING AFTER ENDOVASCULAR THERAPY OF ISOLATED INFRAPOPLITEAL LESIONS UNDERLYING CRITICAL LIMB ISCHEMIA IN PATIENTS WITH HIGH PREVALENCE OF DIABETES MELLITUS AND HEMODIALYSIS.- BILATERAL INTERNAL THORACIC ARTERY HARVEST AND DEEP STERNAL WOUND INFECTION IN DIABETIC PATIENTS.- ROLE OF TOPICAL APPLICATION OF GENTAMICIN CONTAINING COLLAGEN IMPLANTS IN CARDIAC SURGERY.- DEEP STERNAL WOUND INFECTION AFTER CARDIAC SURGERY.- SCORING SYSTEM TO GUIDE DECISION MAKING FOR THE USE OF GENTAMICIN-IMPREGNATED COLLAGEN SPONGE TO PREVENT DEEP STERNAL WOUND INFECTION.
PART 2: NEUROSURGERY WOUND MANAGEMENT AND WOUND INFECTIONS IN NEUROSURGERY.- CALCIUM PHOSPHATE CEMENT CRANIOPLASTY DECREASES THE RATE OF CEREBROSPINAL FLUID LEAK AND WOUND INFECTION COMPARED WITH TITANIUM MESH CRANIOPLASTY.
PART 3: LOWER EXTREMITY ULCERS PATHOPHYSIOLOGY OF WOUND HEALING AND ALTERATIONS IN VENOUS LEG ULCERS.- CRITICAL EVALUATION OF DELAYED HEALING OF VENOUS LEG ULCERS.
PART 4: ANTIMICROBIAL THERAPY ANTIMICROBIAL THERAPY IN THE BIOFILM AGE.- DEVELOPMENT OF SUBERIN FATTY ACIDS AND CHLORAMPHENICOL-LOADED ANTIMICROBIAL ELECTROSPUN NANOFIBROUS MATS INTENDED FOR WOUND THERAPY.- PHARMACOKINETICS OF LEVOFLOXACIN IN BURN INJURY PATIENTS.- BACTERIOLOGY OF NAJA ATRA SNAKEBITE WOUND AND ITS IMPLICATIONS FOR ANTIBIOTIC THERAPY.
PART 5: WOUND ASSESSMENT, CARE, MEASUREMENT NONINVASIVE IMAGING TECHNOLOGIES FOR CUTANEOUS WOUND ASSESSMENT.- WOUND CARE IN THE HOSPICE AND PALLIATIVE SETTING.- MANAGING PATIENTS WITH FISTULAS.- MOREL-LAVALLEE LESION: A CLOSED DEGLOVING INJURY THAT REQUIRES REAL ATTENTION.- MANAGING WOUNDS IN CANCER PATIENTS.- THE ROLE OF INADINE IN WOUND CARE: A CONSENSUS DOCUMENT.- THE USE OF AUTOLOGOUS FAT GRAFTING FOR TREATMENT OF SCAR TISSUE AND SCAR-RELATED CONDITIONS.- THE RELIABILITY OF A NOVEL MOBILE 3-DIMENSIONAL WOUND MEASUREMENT DEVICE.- NON-INVASIVE OBJECTIVE DEVICES FOR MONITORING THE INFLAMMATORY, PROLIFERATIVE AND REMODELLING PHASES OF CUTANEOUS WOUND HEALING AND SKIN SCARRING.- STEREOLOGICAL QUANTIFICATION OF CELL-CYCLE KINETICS AND MOBILIZATION OF EPITHELIAL STEM CELLS DURING WOUND HEALING.
PART 6: WOUND REPAIR RECONSTRUCTIVE OPTIONS OF ABDOMINAL WOUNDS IN THE SETTING OF ABDOMINAL WALL DEFECTS AND HERNIA.- USE OF A NOVEL ACELLULAR DERMAL MATRIX ALLOGRAFT TO TREAT COMPLEX TRAUMA WOUND.- RADIATION WOUNDS AND THEIR MANAGEMENT: RECONSTRUCTIVE OPTIONS.- PRE-VASCULARIZATION ENHANCES THERAPEUTIC EFFECTS OF HUMAN MESENCHYMAL STEM CELL SHEETS IN FULL THICKNESS SKIN WOUND REPAIR.- IS IT POSSIBLE TO USE AUTOLOGOUS ADIPOSE GRAFT FOR WOUND REPAIR IN PATIENTS WITH COAGULATION DISORDERS?.- A NOVEL RETICULAR DERMAL GRAFT LEVERAGES ARCHITECTURAL AND BIOLOGICAL PROPERTIES TO SUPPORT WOUND REPAIR. - CULTURAL ADAPTATION AND VALIDATION OF THE FREIBURG LIFE QUALITY ASSESSMENT IN CHRONIC WOUNDS.
This book addresses wound care in vascular surgery, neurosurgery and lower extremity ulcers, while also providing detailed information on the latest concepts in antimicrobial therapy. The book presents essential content on the assessment, care, measurement and repair of wounds, and describes important scientific aspects as well as current clinical techniques. Due to the various topics covered, the book offers a valuable resource not only for plastic surgeons, but also for neurosurgeons, vascular surgeons and all clinicians who are interested in learning about current antimicrobial agents and their use.
Dr. Melvin A. Shiffman, MD, JD, FCLM, received his MD from Northwestern University School of Medicine in 1957 and completed his residency in general surgery in 1964 at the Veterans Administration Hospital, Long Beach, California. Since then he has been continuously involved in oncologic surgery, reconstruction, and cosmetic surgery. In 2002, Dr. Shiffman became Chair of the Section of Surgery at Tustin Hospital and Medical Center and in 2009-10 he served as President of the American College of Legal Medicine. He is Editor Emeritus of the American Journal of Cosmetic Surgery, a member of the Scientific Committee of the American Journal of Aesthetic Medicine, and an examiner for the International Board of Cosmetic Surgery. He is also a former Editor-in-Chief of both the American Journal of Cosmetic Surgery and the International Journal of Cosmetic Surgery. Dr. Shiffman is the recipient of many honors and is a fellow of various colleges and societies. He has published 300 articles, authored or edited 34 books, and written more than 140 book chapters.
Dr. Mervin Low, MD received his MD from the University of British Columbia, Vancouver, BC, Canada. He completed his Plastic Surgery Residency at the University of Manitoba, Winnipeg, MB, Canada, and a Breast and Aesthetic Surgery fellowship at Georgetown University in Washington, DC, USA, and at the Plastic Surgery Center of the Pacific, Honolulu, HI, USA. Dr. Low has a busy practice devoted entirely to Aesthetic and Reconstructive Plastic Surgery. He is a prolific author, educator and innovator. He has been recognized locally as one of the Best Doctors in California and nationally as one of the Top Plastic Surgeons in America.